Melincoff Gwen A Insider Trades

Insider Trading History

Track insider trading activity for Melincoff Gwen A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Chemomab Therapeutics
Chemomab Therapeutics CMMB
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2026 Sale
$16k 8,621 shares
$1.86
$1.80
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $30.2k 15,000 shares
Last Trade
Sep 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.6k 15,000 shares
$1.64
$2.01
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $27.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.86
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $27.9k 15,000 shares
Last Trade
Jun 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.4k 15,000 shares
$1.29
$1.86
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.72M 52,468 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$259k 7,693 shares
$33.67
$32.69
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $124k 61,676 shares
Last Trade
Sep 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 61,676 shares
$1.66
$2.01
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $19.5k 10,500 shares
Last Trade
Jun 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.3k 10,500 shares
$4.50
$1.86
Soleno Therapeutics
Soleno Therapeutics SLNO
Director
Holding Value $530k 10,000 shares
Last Trade
May 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.5k 10,000 shares
$5.25
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Director
Holding Value $141k 2,666 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.4k 2,666 shares
$5.03
$53.01
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.46M 44,775 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 9,792 shares
$22.53
$32.69
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $19.5k 10,500 shares
Last Trade
Sep 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.8k 10,500 shares
$3.50
$1.86
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $101k 50,000 shares
Last Trade
Sep 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 100,000 shares
$1.03
$2.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Director
Holding Value $141k 2,666 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$443 2,666 shares
$0.17
$53.01
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.14M 34,983 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$224k 14,035 shares
$15.98
$32.69
Soleno Therapeutics
Soleno Therapeutics SLNO
Director
Holding Value $1.69M 31,862 shares
Last Trade
Jun 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.5k 31,862 shares
$1.02
$53.01
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $685k 20,948 shares
Last Trade
May 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$243k 9,941 shares
$24.40
$32.69
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $0 0 shares
Last Trade
Mar 17, 2021 Sale
No data
No data
$1.86
Soleno Therapeutics
Soleno Therapeutics SLNO
Director
Holding Value $4.34M 81,887 shares
Last Trade
Jan 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.6k 40,000 shares
$2.24
$53.01
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $360k 11,007 shares
Last Trade
May 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 8,095 shares
$22.05
$32.69
Soleno Therapeutics
Soleno Therapeutics SLNO
Director
Holding Value $505k 9,530 shares
Last Trade
May 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.5k 9,530 shares
$3.41
$53.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up